AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay

Xiulei Mo , Qi Qi , Andrei A. Ivanov , Qiankun Niu
Molecular Pharmacology 91 ( 4) 339 -347

23
2017
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016

Andreas Lundqvist , Vincent van Hoef , Xiaonan Zhang , Erik Wennerberg
Journal for immunotherapy of cancer 4 1 -106

10
2016
Protein–Protein Interactions

Hae Ryoun Park , Lisa Montoya Cockrell , Yuhong Du , Andrea Kasinski
Molecular Biomethods Handbook 463 -494

2
2008
Genome-scale neoantigen screening using ATLAS™ prioritizes candidate antigens for immunotherapy in a non-small cell lung cancer patient

Lila Ghamsari , Emilio Flano , Judy Jacques , Biao Liu
Cancer Research 77 ( 13_Supplement) 632 -632

1
2017
Non-cell-autonomous cancer progression from chromosomal instability

Jun Li , Melissa Hubisz , Ethan Earlie , Mercedes Duran
Cancer Research 84 ( 6_Supplement) 6630 -6630

2024
Cross Reactivity of CD8+ T Cell Neo-epitopes to Bifidobacterium Boosts the Tumor Specific Population

Catherine Ami Bessell , Ariel Isser , Jonathan Havel , Timothy Chan
The Journal of Immunology 200 ( 1_Supplement) 57.33 -57.33

2018
β 2-Microglobulin mediated androgen receptor and PSA expression and prostate cancer cell growth and survival

Wen-Chin Huang , Jonathan Havel , Takeo Nomura , Haiyen E Zhau
Cancer Research 67 ( 9_Supplement) 3276 -3276

2007
31st annual meeting and associated programs of the society for immunotherapy of cancer (Sitc 2016): Part two: National harbor, md, USA. 9-13 November 2016

Casey Ager , Matthew Reilley , Courtney Nicholas , Todd Bartkowiak
Journal for ImmunoTherapy of Cancer 4 107 -221

12
2016
Inhibition of Protein-Protein Interactions: Non-Cellular Assay Formats

Michelle R. Arkin , Haian Fu , Marcie A. Glicksman , Jonathan J. Havel
Eli Lilly & Company and the National Center for Advancing Translational Sciences

64
2012
The role of neoantigens in response to immune checkpoint blockade.

Nadeem Riaz , Luc Morris , Jonathan J. Havel , Vladimir Makarov
International Immunology 28 ( 8) 411 -419

63
2016
Time-Resolved Fluorescence Resonance Energy Transfer Technologies in HTS

Yuhong Du , Jonathan J. Havel
Chemical Genomics 198 -214

5
2012
The head and neck cancer immune landscape and its immunotherapeutic implications.

Rajarsi Mandal , Yasin Şenbabaoğlu , Alexis Desrichard , Jonathan J. Havel
JCI insight 1 ( 17)

254
2016
Commensal bacteria stimulate antitumor responses via T cell cross-reactivity

Catherine A. Bessell , Ariel Isser , Jonathan J. Havel , Sangyun Lee
JCI insight 5 ( 8)

11
2020
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Jonathan J. Havel , Diego Chowell , Timothy A. Chan
Nature Reviews Cancer 19 ( 3) 133 -150

1,503
2019
Abstract PR15: Predicting the essentialities of protein-protein interactions in cancer

Lee AD Cooper , Josue D. Moran , Zenggang Li , Yuhong Du
Cancer Research 75

2015
Immunogenic neoantigens derived from gene fusions stimulate T cell responses.

Wei Yang , Ken-Wing Lee , Raghvendra M. Srivastava , Fengshen Kuo
Nature Medicine 25 ( 5) 767 -775

218
2019
β2-Microglobulin Signaling Blockade Inhibited Androgen Receptor Axis and Caused Apoptosis in Human Prostate Cancer Cells

Wen-Chin Huang , Jonathan J. Havel , Haiyen E. Zhau , Wei Ping Qian
Clinical Cancer Research 14 ( 17) 5341 -5347

34
2008
Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions.

Martin G. Dalin , Nora Katabi , Marta Persson , Ken-Wing Lee
Nature Communications 8 ( 1) 1197

60
2017